» Articles » PMID: 36553961

Influencing Appropriate Statin Use in a Charity Care Primary Clinic

Overview
Specialty Health Services
Date 2022 Dec 23
PMID 36553961
Authors
Affiliations
Soon will be listed here.
Abstract

According to the American College of Cardiology/American Heart Association (ACC/AHA) new cholesterol management guidelines in 2019, statin regimen was prescribed to only about 46.4% and 30% of diabetes (DM) patients and patients with atherosclerotic cardiovascular disease (ASCVD), respectively. Atherosclerotic cardiovascular disease accounts for most deaths and disabilities in North America. This study argues that a systematic approach to identifying targeted interventions to adhere to the statin regimen for ASCVD is sparse in previous studies. This study seeks to address the research gap. Besides, the study argues that the statin regimen could improve cholesterol management with the enablers of pharmacy, providers, electronic medical records (E.M.R.), and patients. It paves the way for future research on cardiovascular and statin regimens from different perspectives. Current study has adopted the Qualitative observation method. Accordingly, the study approached the charity care primary clinic serving a large population in the northeastern part of the United States, which constitutes the project's setting. The facility has 51 internal medicine residents. The facility has E.H.R., which is used by the clinical staff. Besides, providers use electronic medication prescribing (E-Scribe). Four PDSA cycles were run in six months. Here, the interventions were intensified during each subsequent cycle. The interventions were then incorporated into routine clinical practice. Based on the observation, the study found a 25% relative improvement by six months based on the baseline data of the appropriate intensity statin prescription for patients with ASCVD or DM by medical resident trainees in our single-center primary care clinic. A total of 77% of cardiovascular disease patients were found to be on an appropriate statin dose at baseline. On the other hand, the proportion of patients with DM who were on proper dose statin was 80.4%. According to the study's findings, PDSA could result in a faster uptake and support of the ACC/AHA guidelines. Evidence indicates that overmedication of persons at low risk and time constraints are some of the most significant impediments to the greater use of prescription medications. Proactive panel management can help improve statins' use by ensuring they are used appropriately.

References
1.
Buse J, Ginsberg H, Bakris G, Clark N, Costa F, Eckel R . Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2006; 30(1):162-72. DOI: 10.2337/dc07-9917. View

2.
Sussman J, Holleman R, Youles B, Lowery J . Quality Improvement and Personalization for Statins: the QUIPS Quality Improvement Randomized Trial of Veterans' Primary Care Statin Use. J Gen Intern Med. 2018; 33(12):2132-2137. PMC: 6258630. DOI: 10.1007/s11606-018-4681-6. View

3.
Stafford R, Blumenthal D, Pasternak R . Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol. 1997; 29(1):139-46. DOI: 10.1016/s0735-1097(96)00441-x. View

4.
Corrao S, Colomba D, Arnone S, Argano C, Di Chiara T, Scaglione R . Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. J Am Med Inform Assoc. 2006; 13(5):485-7. PMC: 1561795. DOI: 10.1197/jamia.M2084. View

5.
Seitz T, Raschauer B, Langle A, Loffler-Stastka H . Competency in medical history taking-the training physicians' view. Wien Klin Wochenschr. 2018; 131(1-2):17-22. PMC: 6342885. DOI: 10.1007/s00508-018-1431-z. View